Metabolic Disorders Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
SKU : PH1331
180 pages
Report Summary
Table of Contents
List of tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Metabolic Disorders Therapeutics Market ?
Global Metabolic Disorders Therapeutics Market reached USD 68.1 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 122.3 billion by 2031.
Who are the Key Players in Metabolic Disorders Therapeutics Market ?
The major global players in the market include Sanofi S.A, Merck KgaA, Amgen, Inc, AstraZeneca PLC, Actelion Pharmaceuticals Ltd, Eli Lilly and Company, Shire PLC, Cipla, Inc, Inc., CymaBay Therapeutics, Inc, and Boehringer Ingelheim GmbH among others.
Related Reports
pharmaceuticalsDiabetes Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 08
Starting from
$4350
pharmaceuticalsType 2 Diabetes Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
Starting from
$4350
pharmaceuticalsObesity Hypoventilation Syndrome Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 03
Starting from
$4350
pharmaceuticalsNeurometabolic Disorders Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 April 25
Starting from
$4350
pharmaceuticalsFamilial Hypercholesterolemia Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 26
Starting from
$4350
pharmaceuticalsOptical Disorders Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 01
Starting from
$4350